RSS feed

Publications (original articles or review articles) published in 2012 from OUS - Department of Oncology

138 publications found

Abbas N, Bruland ØS, Brevik EM, Dahle J (2012)
Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts
Nucl Med Commun, 33 (8), 838-47
DOI 10.1097/MNM.0b013e328354df7c, PubMed 22643311

Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
Acta Oncol, 52 (4), 679-90
DOI 10.3109/0284186X.2012.731521, PubMed 23190360

Andersen MH, Dueland S, Hagness M, Vidnes T, Finstad ED, Wahl AK, Foss A (2012)
Quality of life following liver transplantation in patients with liver metastases from colorectal carcinoma
Scand J Caring Sci, 26 (4), 713-9
DOI 10.1111/j.1471-6712.2012.00984.x, PubMed 22452269

Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients
J Pain Symptom Manage, 43 (4), 694-705
DOI 10.1016/j.jpainsymman.2011.05.008, PubMed 22285284

Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ (2012)
Barriers to the implementation of surveillance for stage I testicular seminoma
Int J Radiat Oncol Biol Phys, 84 (2), 383-9
DOI 10.1016/j.ijrobp.2011.11.064, PubMed 22349043

Barrett ES, Thune I, Lipson SF, Furberg AS, Ellison PT (2012)
A factor analysis approach to examining relationships among ovarian steroid concentrations, gonadotrophin concentrations and menstrual cycle length characteristics in healthy, cycling women
Hum Reprod, 28 (3), 801-11
DOI 10.1093/humrep/des429, PubMed 23250924

Barrett ES, Tran V, Thurston S, Jasienska G, Furberg AS, Ellison PT, Thune I (2012)
Marriage and motherhood are associated with lower testosterone concentrations in women
Horm Behav, 63 (1), 72-9
DOI 10.1016/j.yhbeh.2012.10.012, PubMed 23123222

Bentzen AG, Guren MG, Wanderås EH, Frykholm G, Tveit KM, Wilsgaard T, Dahl O, Balteskard L (2012)
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort
Int J Radiat Oncol Biol Phys, 83 (2), e173-80
DOI 10.1016/j.ijrobp.2011.12.062, PubMed 22436791

Bergh I, Aass N, Haugen DF, Kaasa S, Hjermstad MJ (2012)
Symptom assessment in palliative medicine
Tidsskr Nor Laegeforen, 132 (1), 18-9
DOI 10.4045/tidsskr.11.1083, PubMed 22240824

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S et al. (2012)
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Ann Oncol, 24 (4), 878-88
DOI 10.1093/annonc/mds579, PubMed 23152360

Biedron R, Tangen JM, Maresz K, Hetland G (2012)
Agaricus blazei Murill - immunomodulatory properties and health benefits
Funct. Foods Health Dis., 2 (11), 428-447
DOI 10.31989/ffhd.v2i11.72

Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A (2012)
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
BMC Cancer, 12, 478
DOI 10.1186/1471-2407-12-478, PubMed 23072591

Borgan E, Lindholm EM, Moestue S, Mælandsmo GM, Lingjærde OC, Gribbestad IS, Børresen-Dale AL, Engebraaten O, Sørlie T (2012)
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts
Mol Oncol, 7 (1), 130-42
DOI 10.1016/j.molonc.2012.10.005, PubMed 23142657

Boye K, Nesland JM, Sandstad B, Haugland Haugen M, Mælandsmo GM, Flatmark K (2012)
EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
Br J Cancer, 107 (4), 667-74
DOI 10.1038/bjc.2012.293, PubMed 22782346

Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G (2012)
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer
J Clin Oncol, 30 (32), 4004-10
DOI 10.1200/JCO.2011.40.8914, PubMed 23071246

Brelin S, Loge JH, Skurtveit S, Johannesen TB, Aass N, Ottesen S, Hjermstad MJ (2012)
Antidepressants to cancer patients during the last year of life--a population-based study
Psychooncology, 22 (3), 506-14
DOI 10.1002/pon.3059, PubMed 22392773

Brustugun OT, Helland Å, Fjellbirkeland L, Kleinberg L, Ariansen S, Jebsen P, Scott H, Dønnem T, Bremnes R, Berg T, Grønberg BH, Dai HY, Wahl SG, Mangseth K, Helgeland L (2012)
[Mutation testing for non-small-cell lung cancer]
Tidsskr Nor Laegeforen, 132 (8), 952-5
DOI 10.4045/tidsskr.11.1017, PubMed 22562326

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Bukowski R, Chlebowski RT, Thune I, Furberg AS, Hankins GD, Malone FD, D'Alton ME (2012)
Birth weight, breast cancer and the potential mediating hormonal environment
PLoS One, 7 (7), e40199
DOI 10.1371/journal.pone.0040199, PubMed 22815728

Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iversen PO, Hjermstad MJ (2012)
Symptoms in advanced pancreatic cancer are of importance for energy intake
Support Care Cancer, 21 (1), 219-27
DOI 10.1007/s00520-012-1514-8, PubMed 22684989

Canhão H, Rodrigues AM, Mourão AF, Martins F, Santos MJ, Canas-Silva J, Polido-Pereira J, Pereira Silva JA, Costa JA, Araújo D, Silva C, Santos H, Duarte C, da Silva JA, Pimentel-Santos FM, Branco JC, Karlson EW, Fonseca JE, Solomon DH (2012)
Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
Rheumatology (Oxford), 51 (11), 2020-6
DOI 10.1093/rheumatology/kes184, PubMed 22843791

Cvancarova M, Aagnes B, Fosså SD, Lambert PC, Møller B, Bray F (2012)
Proportion cured models applied to 23 cancer sites in Norway
Int J Cancer, 132 (7), 1700-10
DOI 10.1002/ijc.27802, PubMed 22927104

d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE (2012)
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
J Clin Oncol, 30 (25), 3093-9
DOI 10.1200/JCO.2011.40.2719, PubMed 22851556

Dahl AA, Olssøn I (2012)
Unfavorable health conditions associated with high social anxiety in the elderly: a community-based study
Nord J Psychiatry, 67 (1), 30-7
DOI 10.3109/08039488.2012.668935, PubMed 22429103

Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L (2012)
Contemporary management of postchemotherapy testis cancer
Eur Urol, 62 (5), 867-76
DOI 10.1016/j.eururo.2012.08.014, PubMed 22938868

de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L (2012)
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983
J Clin Oncol, 30 (8), 792-9
DOI 10.1200/JCO.2011.37.0171, PubMed 22271474

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-64
DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol Histopathol, 27 (10), 1315-25
DOI 10.14670/HH-27.1315, PubMed 22936450

Engebraaten O, Edvardsen H, Løkkevik E, Naume B, Kristensen V, Ottestad L, Natarajan V (2012)
Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial
ISRN Oncol, 2012, 176789
DOI 10.5402/2012/176789, PubMed 22666610

Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM (2012)
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma
PLoS One, 7 (9), e45492
DOI 10.1371/journal.pone.0045492, PubMed 23029050

Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D et al. (2012)
Improved survival with MEK inhibition in BRAF-mutated melanoma
N Engl J Med, 367 (2), 107-14
DOI 10.1056/NEJMoa1203421, PubMed 22663011

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
DOI 10.1038/bmt.2012.63, PubMed 22522568

Fløtten Ø, Grønberg BH, Bremnes R, Amundsen T, Sundstrøm S, Rolke H, Hornslien K, Wentzel-Larsen T, Aasebø U, von Plessen C (2012)
Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group
Br J Cancer, 107 (3), 442-7
DOI 10.1038/bjc.2012.284, PubMed 22759880

Fung C, Fossa SD, Beard CJ, Travis LB (2012)
Second malignant neoplasms in testicular cancer survivors
J Natl Compr Canc Netw, 10 (4), 545-56
DOI 10.6004/jnccn.2012.0052, PubMed 22491051

Geisler CH, Kolstad A, Laurell A, Jerkeman M, Räty R, Andersen NS, Pedersen LB, Eriksson M, Nordström M, Kimby E, Bentzen H, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Ehinger M, Sundström C, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E, Nordic Lymphoma Group (2012)
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
Br J Haematol, 158 (3), 355-62
DOI 10.1111/j.1365-2141.2012.09174.x, PubMed 22640180

Grytli HH, Fagerland MW, Fosså SD, Taskén KA, Håheim LL (2012)
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
Prostate, 73 (3), 250-60
DOI 10.1002/pros.22564, PubMed 22821802

Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2012)
Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing
PLoS One, 7 (4), e34150
DOI 10.1371/journal.pone.0034150, PubMed 22529906

Hauglann B, Benth JŠ, Fosså SD, Dahl AA (2012)
A cohort study of permanently reduced work ability in breast cancer patients
J Cancer Surviv, 6 (3), 345-56
DOI 10.1007/s11764-012-0215-0, PubMed 22457217

Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M, Oldenburg J, Dahl AA, Bremnes RM, Fosså SD (2012)
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
J Clin Oncol, 30 (30), 3752-63
DOI 10.1200/JCO.2012.43.4431, PubMed 23008318

Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
Cardiology, 123 (4), 240-7
DOI 10.1159/000343622, PubMed 23207160

Helland Å, Solberg S, Brustugun OT (2012)
Incidence and survival of malignant pleural mesothelioma in norway: a population-based study of 1686 cases
J Thorac Oncol, 7 (12), 1858-1861
DOI 10.1097/JTO.0b013e318275b346, PubMed 23154557

Hjermstad MJ, Bergenmar M, Fisher SE, Montel S, Nicolatou-Galitis O, Raber-Durlacher J, Singer S, Verdonck-de Leeuw I, Weis J, Yarom N, Herlofson BB (2012)
The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients
Eur J Cancer, 48 (14), 2203-11
DOI 10.1016/j.ejca.2012.04.003, PubMed 22572480

Hjermstad MJ, Lie HC, Caraceni A, Currow DC, Fainsinger RL, Gundersen OE, Haugen DF, Heitzer E, Radbruch L, Stone PC, Strasser F, Kaasa S, Loge JH, European Palliative Care Research Collaborative (EPCRC) (2012)
Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA
J Pain Symptom Manage, 44 (5), 639-54
DOI 10.1016/j.jpainsymman.2011.10.025, PubMed 22795905

Hofsø K, Miaskowski C, Bjordal K, Cooper BA, Rustøen T (2012)
Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy
Cancer Nurs, 35 (3), 167-77
DOI 10.1097/NCC.0b013e31821f5eb5, PubMed 21760482

Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C (2012)
Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer
J Pain Symptom Manage, 45 (6), 980-1006
DOI 10.1016/j.jpainsymman.2012.06.003, PubMed 23026547

Holmboe L, Andersen AM, Mørkrid L, Slørdal L, Hall KS (2012)
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
Br J Clin Pharmacol, 73 (1), 106-14
DOI 10.1111/j.1365-2125.2011.04054.x, PubMed 21707700

Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Ostenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M (2012)
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
Ann Oncol, 24 (5), 1385-92
DOI 10.1093/annonc/mds621, PubMed 23247661

Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
PLoS One, 7 (10), e46117
DOI 10.1371/journal.pone.0046117, PubMed 23049692

Haas RL, Delaney TF, O'Sullivan B, Keus RB, Le Pechoux C, Olmi P, Poulsen JP, Seddon B, Wang D (2012)
Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?
Int J Radiat Oncol Biol Phys, 84 (3), 572-80
DOI 10.1016/j.ijrobp.2012.01.062, PubMed 22520481

Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
J Transl Med, 10, 36
DOI 10.1186/1479-5876-10-36, PubMed 22390413

Ingebrigtsen VA, Boye K, Tekle C, Nesland JM, Flatmark K, Fodstad O (2012)
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer
Int J Cancer, 131 (11), 2528-36
DOI 10.1002/ijc.27566, PubMed 22473715

Iversen A, Thune I, McTiernan A, Makar KW, Wilsgaard T, Ellison PT, Jasienska G, Flote V, Poole EM, Furberg AS (2012)
Genetic polymorphism CYP17 rs2486758 and metabolic risk factors predict daily salivary 17β-estradiol concentration in healthy premenopausal Norwegian women. The EBBA-I study
J Clin Endocrinol Metab, 97 (5), E852-7
DOI 10.1210/jc.2011-2577, PubMed 22419734

Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegård T, Reichardt P (2012)
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial
JAMA, 307 (12), 1265-72
DOI 10.1001/jama.2012.347, PubMed 22453568

Johnson E, Førland DT, Hetland G, Sætre L, Olstad OK, Lyberg T (2012)
Effect of AndoSan™ on expression of adhesion molecules and production of reactive oxygen species in human monocytes and granulocytes in vivo
Scand J Gastroenterol, 47 (8-9), 984-92
DOI 10.3109/00365521.2012.660544, PubMed 22564240

Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2012)
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
Scand J Gastroenterol, 47 (8-9), 1021-9
DOI 10.3109/00365521.2012.685754, PubMed 22577871

Kaye S, Aamdal S, Jones R, Freyer G, Pujade-Lauraine E, de Vries EG, Barriuso J, Sandhu S, Tan DS, Hartog V, Kuenen B, Ruijter R, Kristensen GB, Nyakas M, Barrett S, Burke W, Pietersma D, Stuart M, Emeribe U, Boven E (2012)
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours
Br J Cancer, 106 (11), 1728-34
DOI 10.1038/bjc.2012.158, PubMed 22531637

Khullar SM, Tvedt D, Chapman K, Herlofson BB (2012)
Sixty cases of extreme osteonecrosis and osteomyelitis of the mandible and maxilla in a West African population
Int J Oral Maxillofac Surg, 41 (8), 978-85
DOI 10.1016/j.ijom.2012.04.022, PubMed 22652445

Kjersem JB, Ikdahl T, Guren T, Skovlund E, Sorbye H, Hamfjord J, Pfeiffer P, Glimelius B, Kersten C, Solvang H, Tveit KM, Kure EH (2012)
Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
BMC Cancer, 12, 534
DOI 10.1186/1471-2407-12-534, PubMed 23167843

Knappskog S, Chrisanthar R, Løkkevik E, Anker G, Østenstad B, Lundgren S, Risberg T, Mjaaland I, Leirvaag B, Miletic H, Lønning PE (2012)
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Breast Cancer Res, 14 (2), R47
DOI 10.1186/bcr3147, PubMed 22420423

Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E, Norwegian Breast Cancer Group trial NBCG VI, Tollenaar RA, Seynaeve C, Devilee P, Salvesen HB, Dørum A, Hveem K, Vatten L, Lønning PE (2012)
MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk
PLoS One, 7 (4), e36263
DOI 10.1371/journal.pone.0036263, PubMed 22558411

Knudsen AK, Brunelli C, Klepstad P, Aass N, Apolone G, Corli O, Montanari M, Caraceni A, Kaasa S (2012)
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data
Pain, 153 (3), 696-703
DOI 10.1016/j.pain.2011.12.005, PubMed 22264677

Knudsen AK, Aass N, Heitzer E, Klepstad P, Hjermstad MJ, Schippinger W, Brenne E, Kaasa S, Wasteson E, European Palliative Care Research Collaborative (EPCRC) (2012)
Interviews with patients with advanced cancer--another step towards an international cancer pain classification system
Support Care Cancer, 20 (10), 2491-500
DOI 10.1007/s00520-011-1361-z, PubMed 22252546

Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA (2012)
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
Neuro Oncol, 15 (2), 135-47
DOI 10.1093/neuonc/nos287, PubMed 23161774

Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB (2012)
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Hum Reprod, 27 (5), 1525-35
DOI 10.1093/humrep/des075, PubMed 22402210

Kristiansen W, Aschim EL, Andersen JM, Witczak O, Fosså SD, Haugen TB (2012)
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men
Int J Androl, 35 (6), 819-827
DOI 10.1111/j.1365-2605.2012.01297.x, PubMed 22882535

Kristjansson SR, Ronning B, Hurria A, Skovlund E, Jordhoy MS, Nesbakken A, Wyller TB (2012)
A comparison of two pre-operative frailty measures in older surgical cancer patients
J. Geriatr. Oncol., 3 (1), 1-7
DOI 10.1016/j.jgo.2011.09.002

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD (2012)
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer
BJU Int, 111 (2), 221-32
DOI 10.1111/j.1464-410X.2012.11198.x, PubMed 22672151

Larsson C, Kleppestø M, Rasmussen I, Salo R, Vardal J, Brandal P, Bjørnerud A (2012)
Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results
J Magn Reson Imaging, 37 (4), 818-29
DOI 10.1002/jmri.23866, PubMed 23086710

Lindholm EM, Kristian A, Nalwoga H, Krüger K, Nygård S, Akslen LA, Mælandsmo GM, Engebraaten O (2012)
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts
Mol Oncol, 6 (4), 418-27
DOI 10.1016/j.molonc.2012.03.006, PubMed 22521242

Luksch R, Tienghi A, Hall KS, Fagioli F, Picci P, Barbieri E, Gandola L, Eriksson M, Ruggieri P, Daolio P, Lindholm P, Prete A, Bisogno G, Tamburini A, Grignani G, Abate ME, Podda M, Smeland S, Ferrari S (2012)
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
Ann Oncol, 23 (11), 2970-2976
DOI 10.1093/annonc/mds117, PubMed 22771824

Lund-Iversen M, Kleinberg L, Fjellbirkeland L, Helland Å, Brustugun OT (2012)
Clinicopathological characteristics of 11 NSCLC patients with EGFR-exon 20 mutations
J Thorac Oncol, 7 (9), 1471-3
DOI 10.1097/JTO.0b013e3182614a9d, PubMed 22895145

Lægreid IK, Bye A, Aasarød K, Jordhøy M (2012)
Nutritional problems, overhydration and the association with quality of life in elderly dialysis patients
Int Urol Nephrol, 44 (6), 1885-92
DOI 10.1007/s11255-012-0280-3, PubMed 23001608

Laake I, Carlsen MH, Pedersen JI, Weiderpass E, Selmer R, Kirkhus B, Thune I, Veierød MB (2012)
Intake of trans fatty acids from partially hydrogenated vegetable and fish oils and ruminant fat in relation to cancer risk
Int J Cancer, 132 (6), 1389-403
DOI 10.1002/ijc.27737, PubMed 22821174

Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
Tumour Biol, 33 (4), 967-78
DOI 10.1007/s13277-012-0325-3, PubMed 22252524

Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC (2012)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Eur Heart J, 34 (12), 886-893c
DOI 10.1093/eurheartj/ehs262, PubMed 22942338

Mathiesen RR, Borgen E, Renolen A, Løkkevik E, Nesland JM, Anker G, Ostenstad B, Lundgren S, Risberg T, Mjaaland I, Kvalheim G, Lønning PE, Naume B (2012)
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
Breast Cancer Res, 14 (4), R117
DOI 10.1186/bcr3242, PubMed 22889108

Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R (2012)
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
Eur J Cancer, 48 (16), 2993-3000
DOI 10.1016/j.ejca.2012.05.014, PubMed 22677260

Michelsen TM, Dørum A, Cvancarova M, Liavaag AH, Dahl AA (2012)
Association between hysterectomy with ovarian preservation and cardiovascular disease in a Norwegian population-based sample
Gynecol Obstet Invest, 75 (1), 61-7
DOI 10.1159/000345072, PubMed 23220872

Micu E, Baturaite Z, Juzeniene A, Bruland ØS, Moan JE (2012)
Superficial-spreading and nodular melanomas in Norway: a comparison by body site distribution and latitude gradients
Melanoma Res, 22 (6), 460-5
DOI 10.1097/CMR.0b013e3283599cc3, PubMed 23010822

Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD (2012)
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
Am J Hematol, 87 (8), 790-4
DOI 10.1002/ajh.23205, PubMed 22488678

Molloy TJ, Roepman P, Naume B, van't Veer LJ (2012)
A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients
PLoS One, 7 (2), e32426
DOI 10.1371/journal.pone.0032426, PubMed 22384245

Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C (2012)
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
Radiother Oncol, 103 (1), 69-75
DOI 10.1016/j.radonc.2012.01.002, PubMed 22398313

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F et al. (2012)
Risk of treatment-related esophageal cancer among breast cancer survivors
Ann Oncol, 23 (12), 3081-3091
DOI 10.1093/annonc/mds144, PubMed 22745217

Myklebust MP, Li Z, Tran TH, Rui H, Knudsen ES, Elsaleh H, Fluge Ø, Vonen B, Myrvold HE, Leh S, Tveit KM, Pestell RG, Dahl O (2012)
Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer
Br J Cancer, 107 (10), 1684-91
DOI 10.1038/bjc.2012.463, PubMed 23099809

Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
Sarcoma, 2012, 639038
DOI 10.1155/2012/639038, PubMed 22518090

Navalho M, Resende C, Rodrigues AM, Ramos F, Gaspar A, Pereira da Silva JA, Fonseca JE, Campos J, Canhão H (2012)
Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis
Radiology, 264 (3), 823-33
DOI 10.1148/radiol.12112513, PubMed 22723498

Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC (2012)
Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
BMC Genomics, 13, 591
DOI 10.1186/1471-2164-13-591, PubMed 23442169

Nilsson S, Franzén L, Parker C, Tyrrell C, Blom R, Tennvall J, Lennernäs B, Petersson U, Johannessen DC, Sokal M, Pigott K, O'Bryan-Tear CG, Thuresson M, Bolstad B, Bruland ØS (2012)
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases
Clin Genitourin Cancer, 11 (1), 20-6
DOI 10.1016/j.clgc.2012.07.002, PubMed 23021204

Nilsson S, Strang P, Aksnes AK, Franzèn L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland ØS (2012)
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
Eur J Cancer, 48 (5), 678-86
DOI 10.1016/j.ejca.2011.12.023, PubMed 22341993

Nordlund MS, Stieber P, Brustugun OT, Warren DJ, Paus E (2012)
Characteristics and clinical validity of two immunoassays for ProGRP
Tumour Biol, 33 (4), 1105-13
DOI 10.1007/s13277-012-0351-1, PubMed 22399443

Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fosså A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F (2012)
Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
PLoS One, 7 (11), e49705
DOI 10.1371/journal.pone.0049705, PubMed 23185413

Olsen K, Sangvik M, Simonsen GS, Sollid JU, Sundsfjord A, Thune I, Furberg AS (2012)
Prevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population. The Tromsø Staph and Skin Study
Epidemiol Infect, 141 (1), 143-52
DOI 10.1017/S0950268812000465, PubMed 22440487

Paulsen Ø, Aass N, Kaasa S, Dale O (2012)
Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review
J Pain Symptom Manage, 46 (1), 96-105
DOI 10.1016/j.jpainsymman.2012.06.019, PubMed 23149084

Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU, Altmüller J, Baessmann I, Becker C, de Wilde B, Vandesompele J, Böhm D, Ansén S, Gabler F, Wilkening I et al. (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Nat Genet, 44 (10), 1104-10
DOI 10.1038/ng.2396, PubMed 22941188

Pomianowska E, Grzyb K, Westgaard A, Clausen OP, Gladhaug IP (2012)
Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer
Eur J Surg Oncol, 38 (11), 1043-50
DOI 10.1016/j.ejso.2012.07.113, PubMed 22883964

Pomianowska E, Westgaard A, Mathisen Ø, Clausen OP, Gladhaug IP (2012)
Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas
Ann Surg Oncol, 20 (1), 233-41
DOI 10.1245/s10434-012-2592-z, PubMed 22893118

Radu C, Norrlid O, Brændengen M, Hansson K, Isacsson U, Glimelius B (2012)
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients
Acta Oncol, 52 (3), 528-37
DOI 10.3109/0284186X.2012.737022, PubMed 23113591

Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E, Fainsinger R, Bennett MI, European Palliative Care Research Collaborative (EPCRC) (2012)
Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study
Palliat Med, 27 (8), 714-21
DOI 10.1177/0269216312464408, PubMed 23175513

Ree AH, Kristensen AT, Saelen MG, de Wijn R, Edvardsen H, Jovanovic J, Abrahamsen TW, Dueland S, Flatmark K (2012)
Tumor phosphatidylinositol-3-kinase signaling and development of metastatic disease in locally advanced rectal cancer
PLoS One, 7 (11), e50806
DOI 10.1371/journal.pone.0050806, PubMed 23226389

Reidunsdatter RJ, Albrektsen G, Hjermstad MJ, Rannestad T, Oldervoll LM, Lundgren S (2012)
One-year course of fatigue after post-operative radiotherapy in Norwegian breast cancer patients--comparison to general population
Acta Oncol, 52 (2), 239-48
DOI 10.3109/0284186X.2012.742563, PubMed 23210971

Riihijärvi S, Nurmi H, Holte H, Björkholm M, Fluge O, Pedersen LM, Rydström K, Jerkeman M, Eriksson M, Leppä S (2012)
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy
Eur J Haematol, 89 (5), 395-402
DOI 10.1111/ejh.12005, PubMed 22882209

Riis ML, Lüders T, Markert EK, Haakensen VD, Nesbakken AJ, Kristensen VN, Bukholm IR (2012)
Molecular profiles of pre- and postoperative breast cancer tumours reveal differentially expressed genes
ISRN Oncol, 2012, 450267
DOI 10.5402/2012/450267, PubMed 23227362

Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K (2012)
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
BMC Cancer, 12, 333
DOI 10.1186/1471-2407-12-333, PubMed 22853000

Rusten E, Rødal J, Revheim ME, Skretting A, Bruland OS, Malinen E (2012)
Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
Acta Oncol, 52 (6), 1160-7
DOI 10.3109/0284186X.2012.728713, PubMed 23198721

Rustøen T, Valeberg BT, Kolstad E, Wist E, Paul S, Miaskowski C (2012)
The PRO-SELF(©) Pain Control Program improves patients' knowledge of cancer pain management
J Pain Symptom Manage, 44 (3), 321-30
DOI 10.1016/j.jpainsymman.2011.09.015, PubMed 22704056

Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
Patient knowledge of late effects of acute lymphoblastic leukaemia
Tidsskr Nor Laegeforen, 132 (18), 2052-5
DOI 10.4045/tidsskr.12.0153, PubMed 23038194

Sagerup CM, Småstuen M, Johannesen TB, Helland A, Brustugun OT (2012)
Increasing age and carcinoma not otherwise specified: a 20-year population study of 40,118 lung cancer patients
J Thorac Oncol, 7 (1), 57-63
DOI 10.1097/JTO.0b013e3182307f7e, PubMed 21900838

Sahlberg KK, Hongisto V, Edgren H, Mäkelä R, Hellström K, Due EU, Moen Vollan HK, Sahlberg N, Wolf M, Børresen-Dale AL, Perälä M, Kallioniemi O (2012)
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
Mol Oncol, 7 (3), 392-401
DOI 10.1016/j.molonc.2012.10.012, PubMed 23253899

Sartor O, Hoskin P, Bruland OS (2012)
Targeted radio-nuclide therapy of skeletal metastases
Cancer Treat Rev, 39 (1), 18-26
DOI 10.1016/j.ctrv.2012.03.006, PubMed 22534284

Schee K, Boye K, Abrahamsen TW, Fodstad Ø, Flatmark K (2012)
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
BMC Cancer, 12, 505
DOI 10.1186/1471-2407-12-505, PubMed 23121918

Schou Bredal I, Kåresen R, Skaane P, Engelstad KS, Ekeberg Ø (2012)
Recall mammography and psychological distress
Eur J Cancer, 49 (4), 805-11
DOI 10.1016/j.ejca.2012.09.001, PubMed 23021930

Skretting A, Evensen JF, Løndalen AM, Bogsrud TV, Glomset OK, Eilertsen K (2012)
A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT
Acta Oncol, 52 (3), 636-44
DOI 10.3109/0284186X.2012.718095, PubMed 23075421

Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2012)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study
Ann Oncol, 24 (1), 152-60
DOI 10.1093/annonc/mds276, PubMed 22967994

Sorensen T, Dahl AA, Fossa SD, Holmen J, Lien L, Danbolt LJ (2012)
Is 'Seeking God's Help' Associated with Life Satisfaction and Disease-specific Quality of Life in Cancer Patients? The HUNT Study
Arch. Psychol. Relig., 34 (2), 191-213
DOI 10.1163/15736121-12341237

Steindal SA, Ranhoff AH, Bredal IS, Sørbye LW, Lerdal A (2012)
Last three days of life in the hospital: a comparison of symptoms, signs and treatments in the young old and the oldest old patients using the Resident assessment instrument for palliative care
Int J Older People Nurs, 8 (3), 199-206
DOI 10.1111/j.1748-3743.2012.00313.x, PubMed 22329702

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B (2012)
Sleep problems in Parkinson's disease: a community-based study in Norway
BMC Neurol, 12, 71
DOI 10.1186/1471-2377-12-71, PubMed 22883600

Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2012)
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
Acta Oncol, 52 (1), 91-101
DOI 10.3109/0284186X.2012.713508, PubMed 22934555

Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B (2012)
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
BMC Cancer, 12, 616
DOI 10.1186/1471-2407-12-616, PubMed 23259667

Syse A, Aas GB, Loge JH (2012)
Children and young adults with parents with cancer: a population-based study
Clin Epidemiol, 4, 41-52
DOI 10.2147/CLEP.S28984, PubMed 22442635

Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG (2012)
Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei
Eur J Surg Oncol, 38 (10), 969-76
DOI 10.1016/j.ejso.2012.06.552, PubMed 22763244

Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD (2012)
A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design
BMC Cancer, 12, 123
DOI 10.1186/1471-2407-12-123, PubMed 22458865

Torp S, Grimsmo A, Hagen S, Duran A, Gudbergsson SB (2012)
Work engagement: a practical measure for workplace health promotion?
Health Promot Int, 28 (3), 387-96
DOI 10.1093/heapro/das022, PubMed 22692482

Torp S, Nielsen RA, Fosså SD, Gudbergsson SB, Dahl AA (2012)
Change in employment status of 5-year cancer survivors
Eur J Public Health, 23 (1), 116-22
DOI 10.1093/eurpub/ckr192, PubMed 22227027

Torp S, Nielsen RA, Gudbergsson SB, Fosså SD, Dahl AA (2012)
Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study
J Cancer Surviv, 6 (3), 315-23
DOI 10.1007/s11764-012-0228-8, PubMed 22706884

Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, Sigurdsson F, Kure E, Ikdahl T, Skovlund E, Fokstuen T, Hansen F, Hofsli E, Birkemeyer E, Johnsson A, Starkhammar H, Yilmaz MK, Keldsen N, Erdal AB, Dajani O, Dahl O, Christoffersen T (2012)
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study
J Clin Oncol, 30 (15), 1755-62
DOI 10.1200/JCO.2011.38.0915, PubMed 22473155

Tveteraas IH, Müller KM, Aasrum M, Ødegård J, Dajani O, Guren T, Sandnes D, Christoffersen T (2012)
Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells
J Exp Clin Cancer Res, 31 (1), 72
DOI 10.1186/1756-9966-31-72, PubMed 22967907

Tørris C, Thune I, Emaus A, Finstad SE, Bye A, Furberg AS, Barrett E, Jasienska G, Ellison P, Hjartåker A (2012)
Duration of lactation, maternal metabolic profile, and body composition in the Norwegian EBBA I-study
Breastfeed Med, 8 (1), 8-15
DOI 10.1089/bfm.2012.0048, PubMed 23057641

Vistad I, Cvancarova M, Salvesen HB (2012)
Follow-up of gynecological cancer patients after treatment - the views of European experts in gynecologic oncology
Acta Obstet Gynecol Scand, 91 (11), 1286-92
DOI 10.1111/j.1600-0412.2012.01523.x, PubMed 22880840

Wahlin BE, Sander B, Christensson B, Ostenstad B, Holte H, Brown PD, Sundström C, Kimby E (2012)
Entourage: the immune microenvironment following follicular lymphoma
Blood Cancer J, 2 (1), e52
DOI 10.1038/bcj.2011.53, PubMed 22829236

Waldeland E, Brustugun OT, Ramberg C, Helland Å (2012)
[Stereotactic irradiation in spinal metastases]
Tidsskr Nor Laegeforen, 132 (22), 2478-9
DOI 10.4045/tidsskr.12.1108, PubMed 23338027

Waldeland E, Ramberg C, Arnesen MR, Helland A, Brustugun OT, Malinen E (2012)
Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors
Acta Oncol, 51 (5), 603-9
DOI 10.3109/0284186X.2012.658115, PubMed 22304490

Westgaard A, Pomianowska E, Clausen OP, Gladhaug IP (2012)
Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Ann Surg Oncol, 20 (2), 430-9
DOI 10.1245/s10434-012-2603-0, PubMed 22956064

Wilberg P, Hjermstad MJ, Ottesen S, Herlofson BB (2012)
Oral health is an important issue in end-of-life cancer care
Support Care Cancer, 20 (12), 3115-22
DOI 10.1007/s00520-012-1441-8, PubMed 22434497

Wist EA, Mjaaland I, Løkkevik E, Sommer HH (2012)
Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
J Oncol, 2012, 862921
DOI 10.1155/2012/862921, PubMed 22291703

Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H (2012)
Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
Leuk Lymphoma, 53 (10), 1934-44
DOI 10.3109/10428194.2012.682307, PubMed 22475179

Ziomkiewicz A, Pawlowski B, Ellison PT, Lipson SF, Thune I, Jasienska G (2012)
Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue
Biol Psychol, 91 (3), 376-82
DOI 10.1016/j.biopsycho.2012.08.001, PubMed 22906865